首页> 外文期刊>International journal of high dilution research >Isoprophylaxis is neither homeoprophylaxis nor homeopathic immunization, but isopathic immunization unsupported by the homeopathic epistemological model: A response to Golden
【24h】

Isoprophylaxis is neither homeoprophylaxis nor homeopathic immunization, but isopathic immunization unsupported by the homeopathic epistemological model: A response to Golden

机译:同种预防既不是同种免疫也不是顺势免疫,而是同种免疫认识论模型所不支持的同种免疫:对Golden的反应

获取原文
       

摘要

Homeopathy might be employed for the prevention of epidemic diseases (homeoprophylaxis) provided remedies are selected on an individual basis in compliance with the ‘principle of symptom-based similitude’ and according to the totality of symptoms peculiar to a given epidemic (remedy of the ‘epidemic genius’ or ‘genus epidemicus), as countless examples in the literature show. The use of nosodes for the prevention of epidemic diseases (isoprophylaxis), i.e., selected based on the ‘principle of etiological identity’ with full neglect of symptom-based individualization and pathogenetic trials, is not supported by the homeopathic epistemological model. As long as there are no reliable scientific evidences attesting to its efficacy and safety, ‘isopathic immunization’ might not be indicated as a regular replacement of classical immunization, as it would mean a transgression of the bioethical principles of beneficence and non-maleficence. Although many homeopathic practitioners systematically indicate that practice, it is condemned by homeopathic institutions worldwide. In this article, I elaborate on epistemological, ethical and scientific features of these disparate approaches to prophylaxis, which I had summarily addressed in a previous review.
机译:顺势疗法可用于预防流行病(顺势疗法),前提是应根据“以症状为基础的相似性原则”并根据特定于流行病的症状总数(“治疗方法”流行天才”或“流行病天才”),如文献中无数的例子所示。顺势疗法的认识论模型不支持将结节性疾病用于预防流行病(等速预防),即基于“病因学原理”进行选择,而完全不考虑基于症状的个体化和致病性试验。只要没有可靠的科学证据证明其有效性和安全性,“同种免疫”可能不会被视为常规免疫的常规替代品,因为这将意味着对良性和非恶性生物伦理原则的侵犯。尽管许多顺势疗法从业者系统地表明这种做法,但全世界的顺势疗法机构都谴责这种做法。在本文中,我详细介绍了这些不同预防方法的认识论,伦理和科学特征,这些我在先前的评论中已作了总结。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号